How many clinical trials are studying [18F]PI-2620?

3 recruiting trials in our tracked data involve [18F]PI-2620.

What conditions is [18F]PI-2620 being studied for?

In our tracked recruiting trials, [18F]PI-2620 is being studied in trials for Alzheimer Disease, Alzheimer's disease, Cognitively Normal.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 1 Phase 3 2

Condition	Trials
Alzheimer Disease	2
Alzheimer's disease	2
Cognitively Normal	1
Frontotemporal Lobar Degeneration	1
Parkinson's Disease	1

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
NCT07020026 · Phase: Phase 2 · Ages: 45 Years to 85 Years · Sex: All (male and female) · 1 location
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
NCT05456503 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
[18F]PI-2620 Phase 3 Histopathological Study
NCT05641688 · Phase: Phase 3 · Ages: 50 Years and older · Sex: All (male and female) · 25 locations